MARIALIZA V BERNARDO

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology HOUSTON, TX NPI 1477551968

General Payments — all program years on this page

$6,811.36

Category: General Payments
Program years: PY2018–2024
Record count: 301
As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,207.73 across 54 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated

The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of payment	Amount	Records
Food and Beverage	$1,190.84	53
Education	$16.89	1

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entity	Amount	Records
Amgen Inc.	$294.36	10
Otsuka America Pharmaceutical, Inc.	$111.89	4
Bayer HealthCare Pharmaceuticals Inc.	$84.98	4
OPKO Pharmaceuticals, LLC	$82.65	5
Ardelyx, Inc.	$79.93	4
ANI Pharmaceuticals, Inc.	$70.76	3
Retrophin, Inc.	$66.87	4
Aurinia Pharma U.S., Inc.	$63.78	3
CorMedix Inc.	$53.48	2
Boehringer Ingelheim Pharmaceuticals, Inc.	$47.44	2
Acerta Pharma LLC	$43.55	2
AKEBIA THERAPEUTICS INC	$38.72	2
Novo Nordisk AS	$37.26	2
Fresenius USA Marketing, Inc.	$36.20	2
GENZYME CORPORATION	$28.73	1
Relypsa, Inc.	$27.58	2
Alexion Pharmaceuticals, Inc.	$21.48	1
Lilly USA, LLC	$18.07	1

By program year

Program year	Amount	Records
2018	$1,578.22	39
2019	$856.64	48
2020	$501.50	27
2021	$913.75	44
2022	$819.35	43
2023	$934.17	46
2024	$1,207.73	54

Records — PY2024 (54)

Record ID	Paying entity	Amount	Date	Nature of payment	Dispute status	Published	Source
1082026331	CorMedix Inc.	$24.53	09/11/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1082026335	CorMedix Inc.	$28.95	06/05/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1086121754	Bayer Healthcare Pharmaceuticals Inc.	$17.22	03/21/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1086217529	Bayer Healthcare Pharmaceuticals Inc.	$24.02	08/29/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1086251414	Bayer Healthcare Pharmaceuticals Inc.	$26.37	05/24/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1086257162	Bayer Healthcare Pharmaceuticals Inc.	$17.37	12/14/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1091134689	ANI Pharmaceuticals, Inc.	$21.94	01/26/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1091136225	ANI Pharmaceuticals, Inc.	$22.77	10/17/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1091166586	ANI Pharmaceuticals, Inc.	$26.05	02/15/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1093975558	Alexion Pharmaceuticals, Inc.	$21.48	01/27/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1096840010	Novo Nordisk Inc	$21.42	10/04/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1097739613	Novo Nordisk Inc	$15.84	05/09/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1104337138	AstraZeneca Pharmaceuticals LP	$23.14	01/13/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1105369903	AstraZeneca Pharmaceuticals LP	$20.41	11/23/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1111529120	Amgen Inc.	$5.00	04/18/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1111529122	Amgen Inc.	$16.41	04/18/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1111529124	Amgen Inc.	$25.82	07/11/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1111529126	Amgen Inc.	$30.12	10/11/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1111529128	Amgen Inc.	$125.00	08/01/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1111529130	Amgen Inc.	$21.03	12/10/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1111529132	Amgen Inc.	$24.46	06/13/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1112842664	OPKO Pharmaceuticals, LLC	$15.10	02/09/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1112842666	OPKO Pharmaceuticals, LLC	$16.65	04/13/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1112842668	OPKO Pharmaceuticals, LLC	$13.47	06/07/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1112842670	OPKO Pharmaceuticals, LLC	$19.65	09/27/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1112842672	OPKO Pharmaceuticals, LLC	$17.78	11/21/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1117202446	Amgen Inc.	$7.43	03/01/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1117202448	Amgen Inc.	$14.40	02/02/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1117202450	Amgen Inc.	$24.69	09/06/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1118025161	Boehringer Ingelheim Pharmaceuticals, Inc.	$16.75	01/05/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1118025163	Boehringer Ingelheim Pharmaceuticals, Inc.	$30.69	04/26/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1118861713	Otsuka America Pharmaceutical, Inc.	$28.07	01/19/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1118861715	Otsuka America Pharmaceutical, Inc.	$28.39	05/31/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1118861717	Otsuka America Pharmaceutical, Inc.	$26.83	09/20/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1118861719	Otsuka America Pharmaceutical, Inc.	$28.60	12/07/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1124052341	Vifor Pharma, Inc.	$13.09	07/02/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1124052349	Vifor Pharma, Inc.	$14.49	07/02/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1135166015	Lilly USA, LLC	$18.07	10/14/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1139623819	GENZYME CORPORATION	$28.73	08/30/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1145827414	AKEBIA THERAPEUTICS INC	$14.60	06/27/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1145831321	AKEBIA THERAPEUTICS INC	$24.12	10/18/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1146671403	Ardelyx, Inc.	$21.38	06/15/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1146671405	Ardelyx, Inc.	$18.98	08/02/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1146671407	Ardelyx, Inc.	$25.09	09/05/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1146671409	Ardelyx, Inc.	$14.48	12/20/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1149897231	Travere Therapeutics, Inc.	$14.09	02/22/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1149897235	Travere Therapeutics, Inc.	$15.89	03/22/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1149897239	Travere Therapeutics, Inc.	$16.89	01/11/2024	Education	Undisputed	01/23/2026	View at CMS
1149897243	Travere Therapeutics, Inc.	$20.00	01/11/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1150676557	Aurinia Pharma U.S., Inc.	$27.62	01/18/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1150676559	Aurinia Pharma U.S., Inc.	$19.96	04/04/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1150676561	Aurinia Pharma U.S., Inc.	$16.20	06/06/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1154210494	Fresenius USA Marketing, Inc.	$16.07	04/05/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1154210496	Fresenius USA Marketing, Inc.	$20.13	12/12/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS

Provenance & corrections

Dataset: CMS Open Payments — General Payments
Source: CMS Open Payments dataset (bulk file)
Publisher of source data: Centers for Medicare & Medicaid Services
Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.